Prelude Therapeutics Inc·4

Mar 22, 6:01 PM ET

Chardonnet Laurent 4

4 · Prelude Therapeutics Inc · Filed Mar 22, 2022

Insider Transaction Report

Form 4
Period: 2022-03-21
Chardonnet Laurent
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2022-03-21$7.51/sh+6,500$48,81514,500 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION